The clinical presentation of diabetic ketoacidosis in pregnancy is usually the same as in nonpregnant women, although the blood glucose may not be as high as in the nongravid state. We report a case of a pregnant woman who developed diabetic ketoacidosis with a normal blood glucose and review the pertinent medical literature. A 29-year-old woman with type I diabetes developed diabetic ketoacidosis during induction of labor. She had a glucose level of 87 mg per 100 ml with ketonuria, a metabolic acidosis, and an anion gap of 20 mmol l À1 . Normoglycemic diabetic ketoacidosis during pregnancy is truly unusual but can occur with relatively low, or even normal, blood sugars and necessitates prompt recognition and treatment. In this case, the combination of an initial episode of hypoglycemia and subsequent blood glucose levels below 95 mg per 100 ml led to a prolonged delay in the initiation of a planned insulin infusion for insulin coverage during the induction of labor. A significant ketoacidosis consequently developed, despite the absence of even a single elevated blood glucose measurement. This case illustrated the importance of not withholding insulin in a patient with type I diabetes for more than a few hours even if the blood glucose is normal.
Introduction
Normal pregnancy is characterized by a state of decreased insulin sensitivity, as well as accelerated lipolysis and ketogenesis. [1] [2] [3] [4] The concentration of serum ketones has been estimated to be two to four times greater than in the nonpregnant state. 1, 5 In addition, pregnant women have a respiratory alkalosis, lowering the serum bicarbonate concentration, thus reducing the capacity to buffer hydrogen ions. Despite these changes, the incidence of diabetic ketoacidosis (DKA) in pregnant diabetic women is only 1 to 3%. 6, 7 Ketoacidosis is associated with increased risks to the mother and fetus. Fetal mortality rates as high as 30 to 90% have been reported, although more recently, it has decreased to as low as 9% due to better prenatal care and diabetic management. 2, 3, 8 The clinical presentation of DKA in pregnancy is usually the same as in nonpregnant women. In most patients, there is hyperglycemia and ketonemia with a high anion gap metabolic acidosis. However, the blood glucose may not be as high as in the nongravid state. Both the fetus and placenta utilize large quantities of glucose resulting in lower maternal fasting glucose levels.
2,3,4,7 Several cases of 'normoglycemic' DKA have been reported in the literature, but the lowest fasting glucose level reported has been 128 mg per 100 ml, a value that by current definitions is elevated. 6, 9, 10 We report the case of a 29-year-old G2P0101 woman with class C type I diabetes for 24 years who truly had normoglycemic DKA. At the time the diagnosis was established her highest blood glucose was 93 mg per 100 ml.
Case presentation
A 29-year-old G2P0101 woman with type I diabetes for 24 years was admitted to the hospital at 24 weeks gestation with poor diabetic control, nausea, vomiting and preterm labor. At the time of admission her hemoglobin A1c was 6.6%. Her preterm labor was arrested with magnesium sulfate. At 29 weeks gestation she had preterm premature rupture of membranes. She was treated with 7 days of antibiotics. Her diabetic condition improved and she was under good control with 30 units of neutral protamine Hagedorn insulin and 19 units of regular insulin in the morning, 16 units of regular insulin at supper and 16 units of neutral protamine Hagedorn insulin at bedtime. During the hospitalization there was no evidence of any infection and she did not receive steroids for fetal lung maturation. At 34 weeks gestation a pitocin induction and an intravenous infusion of 0.9% NaCl was begun at 0800 hours with a blood glucose of 67 mg per 100 ml. The plan was to start intravenous infusions of insulin and glucose when the blood glucose exceeded 100 mg per 100 ml. Over the next 24 h her blood glucose ranged from 45 to 93 mg per 100 ml without insulin (Table 1) . At this time she was still in labor without nausea or other symptoms suggesting ketoacidosis. Her laboratory tests included sodium 144 mmol l À1 , potassium 4.0 mmol l À1 , bicarbonate 12 mmol l À1 , chloride 112 mmol l À1 , anion gap 20 mmol l À1 , BUN 14 mg per 100 ml, creatinine 0.7 mg per 100 ml, urine ketones 50 mg per 100 ml, urine glucose negative, arterial pH 7.22, P CO2 27 and P O2 120. An insulin infusion of 1 unit per hour along with D5 0.45% NaCl at 125 cc h À1 was initiated to treat DKA. Glucose levels were measured hourly and the insulininfusion rate varied from 1 to 2 units per hour to keep the glucose between 80 and 150 mg per 100 ml. After 8 h of treatment DKA resolved and she had a normal anion gap of 9 mmol l
À1
. Pitocin was discontinued because of the failure of labor to progress. The patient delivered a 3273-g girl by C-section with APGAR score of 5 at 1 min and 9 at 5 min.
Discussion
Diabetic ketoacidosis is a life-threatening, acute metabolic state that is due to insulin deficiency. Low levels of insulin increase hepatic glucose production while decreasing glucose uptake and utilization. DKA is also characterized by increased levels of the counter-regulatory hormones glucagon, cortisol, catecholamines and growth hormone. These hormones accelerate the development of ketoacidosis by increasing gluconeogenesis, glycogenolysis, ketogenesis and insulin resistance. Insulin deficiency increases hormone-sensitive lipase, releasing large quantities of free fatty acids from adipocytes. In the presence of high-glucagon and low-insulin levels free fatty acids are metabolized in the liver to acetoacetic acid and b-hydroxybutyric acid. The hydrogen ions that dissociate from these strong organic acids are buffered by bicarbonate leading to a high anion gap metabolic acidosis. The hyperglycemia and hyperosmolality seen in patients with DKA produce the characteristic osmotic diuresis, which ultimately leads to intravascular volume depletion. If this is not corrected by the administration of intravenous fluids and insulin, DKA can rapidly progress to a state of poor tissue perfusion, diminished cardiac and renal function, multisystem failure and death.
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While the clinical presentation of DKA in pregnant women is usually similar to that in nonpregnant women, a number of changes during pregnancy can influence carbohydrate and fat metabolism. [2] [3] [4] 8 Placental lactogen and increased levels of cortisol both contribute to increased insulin resistance, particularly toward the later stages of pregnancy. Pregnant women have a respiratory alkalosis with decreased serum bicarbonate concentrations and a reduced capacity to buffer organic acids. Furthermore, pregnancy is considered to be an accelerated state of starvation in which an overnight fast can lead to increased lipolysis and ketone body concentrations that are two to four times greater than in the nonpregnant state. 1, 5 Factors that may predispose pregnant woman to develop DKA include starvation, the stress of labor, cessation of insulin therapy, use of b sympathomimetic agents for premature labor and emesis with accompanying dehydration.
It is well recognized that when DKA complicates pregnancy the initial serum glucose concentration may not be as high as in men or nonpregnant women. In pregnancy during periods of fasting, glycogenolysis, lipolysis and ketone production are increased. Under these conditions DKA can develop more rapidly and at lower serum concentrations of glucose than in nonpregnant women. [2] [3] [4] 7 Rare cases of 'euglycemic' DKA in pregnancy have been reported, although in almost every case the serum glucose has exceeded 130 mg per 100 ml. Normoglycemic DKA in pregnancy M Chico et al
Cullen et al. 6 reported their experience with 20 patients with DKA complicating pregnancy over a period of 10 years. The mean glucose concentration was 323 mg per 100 ml (range of 130 to 682 mg per 100 ml). In 36% of these cases the glucose was less than 200 mg per 100 ml, with the lowest recorded value of 130 mg per 100 ml. Montero et al. 7 described their experience with 20 cases of DKA in pregnant women cared for from 1972 to 1987. In patients with viable fetuses the mean glucose concentration was 374 mg per 100 ml. Two had a serum glucose of less than 200 mg per 100 ml (156 and 180 mg per 100 ml).
At the time our patient was diagnosed as having DKA, she had a serum glucose of 87 mg per 100 ml, bicarbonate concentration of 12 mmol l À1 and an anion gap of 20 mmol l À1 . Over the preceding 24 h her highest glucose was 93 mg per 100 ml. In our patient the serum glucose concentration was <100 mg per 100 ml at the time her anion gap was 20 mmol l
À1
. In addition, she was asymptomatic with none of the expected clinical features of DKA such as vomiting, polyuria, hypotension or changes in her mental status. It is possible that starvation ketosis contributed to the development of the high anion gap metabolic acidosis in our patient. However, it is unlikely that starvation ketosis alone could lead to such a severe degree of ketoacidosis with a pH of 7.22, bicarbonate of 12 mmol l À1 and an anion gap 20 mmol l À1 . The initial reason for withholding insulin infusion in our patient was that her blood glucose was noted to be in the hypoglycemic range on the morning of induction. At that time she may have been subject to some residual effect of the prior evening's bedtime dose of neutral protamine Hagedorn insulin. It was anticipated that within a few hours the blood glucose would rise to 100 mg per 100 ml at which time an intravenous insulin infusion could be initiated. However, the blood glucose persisted in the hypoglycemic range for over 8 h and never even reached a level of 95 mg per 100 ml. Since the patient was NPO with low and later normal blood glucose levels, the decision to begin the infusion was not made until the next morning. At that point it was realized that the prior dose of neutral protamine Hagedorn insulin had long since worn off and that ketoacidosis likely had developed.
During the first 24 h of the induction of labor, when the patient was not eating and not receiving any intravenous glucose, the absence of caloric intake combined with the muscular activity of uterine contractions likely contributed to the both the low blood glucose and the generation of ketones. However, ketoacidosis would be expected to occur even in the absence of these factors given the long interval without insulin effect. This case highlights the importance of not withholding insulin for more than a few hours in a patient with type I diabetes. It further illustrates the hazard of relying solely on the glucose level as an index of insulin activity, especially in clinical settings such as this one where multiple factors act together to keep blood glucose levels low. Clearly, the better approach in this case would have been to resolve the initial hypoglycemia with intravenous glucose and to begin combined insulin and dextrose infusions as soon as the glucose was no longer low.
While it is well established that DKA in pregnancy can occur with only modestly elevated serum glucose level, our literature review did not identify any previous reports with truly normal serum glucose concentrations.
Conclusion
We conclude that the degree of hyperglycemia in pregnancy complicated by DKA may be blunted due to decreased glucose production or increased glucose utilization. Normoglycemic DKA during pregnancy is truly unusual but can occur with relatively low, or even normal, blood sugars and necessitates prompt recognition and treatment. This emphasizes the importance of not withholding insulin for more than a few hours in a patient with type I diabetes, even in the presence of a normal blood glucose. If patients are not receiving subcutaneous insulin they should be treated with an intravenous infusion of dextrose along with intravenous insulin to maintain normal glucose levels.
